BioTime, Inc. (BTX) reported a net loss for the first quarter of $7.7 million or $0.15 per share, compared to a net loss of $5.0 million or $0.10 per share for the year-ago quarter.
Total net revenue for the fell to $431,724 from $631,946 a year ago, due to to lower grant revenue related to the completion of BioTime's research grant from the California Institute for Regenerative Medicine in August 2012, partially offset by subscription and advertising revenues from LifeMap Science's online database GeneCards which LifeMap Sciences began marketing in May 2012.
For comments and feedback: editorial@rttnews.com